logo
#

Latest news with #RyanSpecialtyHoldings

Should You Hold Ryan Specialty Holdings (RYAN)?
Should You Hold Ryan Specialty Holdings (RYAN)?

Yahoo

time6 days ago

  • Business
  • Yahoo

Should You Hold Ryan Specialty Holdings (RYAN)?

Fred Alger Management, an investment management company, released its 'Alger Mid Cap Focus Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets regained their strength in the second quarter of 2025. Class A shares of the fund outperformed the Russell Midcap Growth Index during the quarter. The Industrials and Energy sectors contributed to the relative performance of the strategy in the quarter, while Information Technology and Consumer Discretionary sectors detracted. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second quarter 2025 investor letter, Alger Mid Cap Focus Fund highlighted stocks such as Ryan Specialty Holdings, Inc. (NYSE:RYAN). Ryan Specialty Holdings, Inc. (NYSE:RYAN) is a specialty products and solutions provider for insurance brokers, agents, and carriers. The one-month return of Ryan Specialty Holdings, Inc. (NYSE:RYAN) was -4.36%, and its shares gained 8.82% of their value over the last 52 weeks. On July 23, 2025, Ryan Specialty Holdings, Inc. (NYSE:RYAN) stock closed at $64.30 per share, with a market capitalization of $16.885 billion. Alger Mid Cap Focus Fund stated the following regarding Ryan Specialty Holdings, Inc. (NYSE:RYAN) in its second quarter 2025 investor letter: "Ryan Specialty Holdings, Inc. (NYSE:RYAN) is a leading provider of specialty insurance products and services, acting as a broker between insurance agents, brokers, and carriers. During the quarter, shares detracted from performance due to lower property insurance pricing across the industry, which negatively impacted the company's premium volumes. However, we view this challenge as temporary and continue to believe Ryan Specialty has the potential to grow earnings faster than the overall market through favorable pricing, higher business volumes, and strategic acquisitions." A portrait of a professional insurance broker at their desk, reviewing a policy. Ryan Specialty Holdings, Inc. (NYSE:RYAN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held Ryan Specialty Holdings, Inc. (NYSE:RYAN) at the end of the first quarter, which was 29 in the previous quarter. While we acknowledge the potential of Ryan Specialty Holdings, Inc. (NYSE:RYAN) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we discussed Ryan Specialty Holdings, Inc. (NYSE:RYAN) and its announcement to acquire J.M. Wilson Corporation. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Ryan Specialty to Announce Second Quarter 2025 Financial Results
Ryan Specialty to Announce Second Quarter 2025 Financial Results

Business Wire

time14-07-2025

  • Business
  • Business Wire

Ryan Specialty to Announce Second Quarter 2025 Financial Results

CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) ('Ryan Specialty'), a leading international specialty insurance firm, today announced it will release its Second Quarter 2025 financial results after the stock market closes on Thursday, July 31, 2025. Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on July 31, 2025. Interested parties may access the conference call through the live webcast, which can be accessed via this link or by visiting the Company's Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available at for one year following the call. About Ryan Specialty Founded in 2010, Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. Ryan Specialty provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. Our mission is to provide industry-leading innovative specialty insurance solutions for insurance brokers, agents, and carriers. Learn more at

3 Insider-Owned Growth Companies With Earnings Surging Up To 104%
3 Insider-Owned Growth Companies With Earnings Surging Up To 104%

Yahoo

time01-07-2025

  • Business
  • Yahoo

3 Insider-Owned Growth Companies With Earnings Surging Up To 104%

The United States market has experienced a notable uptick, climbing 2.9% in the last week and 14% over the past year, with earnings forecasted to grow by 15% annually. In this favorable environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders. Name Insider Ownership Earnings Growth Super Micro Computer (SMCI) 13.9% 39.1% Ryan Specialty Holdings (RYAN) 15.5% 91% QT Imaging Holdings (QTIH) 26.7% 84.5% Prairie Operating (PROP) 34.6% 75.7% FTC Solar (FTCI) 28.3% 62.5% Enovix (ENVX) 12.1% 58.4% Credo Technology Group Holding (CRDO) 12% 45% Atour Lifestyle Holdings (ATAT) 21.8% 23.7% Astera Labs (ALAB) 13.1% 44.4% ARS Pharmaceuticals (SPRY) 14.3% 63.1% Click here to see the full list of 195 stocks from our Fast Growing US Companies With High Insider Ownership screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Niagen Bioscience, Inc. is a bioscience company focused on developing healthy aging products with a market cap of $1.12 billion. Operations: The company's revenue is primarily derived from Consumer Products at $80.92 million, followed by Ingredients at $23.90 million, and Analytical Reference Standards and Services at $3.11 million. Insider Ownership: 29.8% Earnings Growth Forecast: 27.6% p.a. Niagen Bioscience shows promising growth potential, with earnings expected to grow significantly over the next three years, outpacing the US market. The company recently reported a strong first quarter with net income of US$5.06 million and increased its revenue guidance for 2025. Despite trading slightly below estimated fair value, Niagen's advancements in NAD+ research and positive clinical trial results underscore its potential in rare disease treatment, enhancing its growth narrative without substantial insider selling activity. Get an in-depth perspective on Niagen Bioscience's performance by reading our analyst estimates report here. The valuation report we've compiled suggests that Niagen Bioscience's current price could be inflated. Simply Wall St Growth Rating: ★★★★☆☆ Overview: LifeStance Health Group, Inc. provides outpatient mental health services across various age groups in the United States and has a market cap of approximately $2 billion. Operations: The company's revenue is primarily derived from mental health services, totaling $1.28 billion. Insider Ownership: 11.3% Earnings Growth Forecast: 104% p.a. LifeStance Health Group exhibits growth potential, with earnings forecast to grow significantly at 104.04% annually, despite revenue expected to grow slower than 20% per year. Recently added to multiple Russell 2000 indices, the company reported a Q1 net income of US$0.71 million and reiterated its full-year revenue guidance of up to US$1.44 billion. Although trading below fair value estimates, insider buying has not been substantial recently but outpaced selling activity slightly. Navigate through the intricacies of LifeStance Health Group with our comprehensive analyst estimates report here. According our valuation report, there's an indication that LifeStance Health Group's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ltd., along with its subsidiaries, develops software applications globally and has a market cap of $15.83 billion. Operations: The company generates revenue of $1.04 billion from its Internet Software & Services segment. Insider Ownership: 13.8% Earnings Growth Forecast: 27.6% p.a. is poised for growth, with earnings projected to rise significantly at 27.6% annually, outpacing the US market. Revenue growth of 18.6% per year also exceeds market averages. Recent executive appointments, including Harris Beber as CMO and Casey George as CRO, aim to bolster marketing and revenue strategies for continued expansion. The company's Q1 results showed a substantial increase in net income to US$27.43 million from US$7.08 million year-over-year, reinforcing its dynamic trajectory amidst evolving tech landscapes. Delve into the full analysis future growth report here for a deeper understanding of Our expertly prepared valuation report implies its share price may be too high. Click through to start exploring the rest of the 192 Fast Growing US Companies With High Insider Ownership now. Searching for a Fresh Perspective? Rare earth metals are the new gold rush. Find out which 24 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include NAGE LFST and MNDY. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Ryan Specialty Reaches Agreement to Acquire J.M. Wilson
Ryan Specialty Reaches Agreement to Acquire J.M. Wilson

Yahoo

time06-06-2025

  • Business
  • Yahoo

Ryan Specialty Reaches Agreement to Acquire J.M. Wilson

Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced that it has entered into a definitive agreement to acquire J.M. Wilson Corporation. Headquartered in Michigan, JM Wilson will be integrated into RT Binding Authority, Ryan Specialty's division focused on binding authority solutions. JM Wilson, established in 1920, operates out of six offices across the US and offers a wide range of insurance products, from personal lines to surety. The firm is especially recognized for its strong expertise in transportation insurance, a complex segment where it has built a reputation for underwriting profitability and maintaining long-term partnerships with top-tier carriers. Commenting on this acquisition, Ed McCormack, CEO of RT Specialty, made the following comment: 'JM Wilson is very well respected in the industry, with its strong underwriting track record and client-focused approach. We are delighted to be able to add such high-quality talent to our organization. This team fills a critical need for RT Specialty, giving us a more robust Midwest binding authority presence and strengthening our transportation practice.' Ryan Specialty Holdings, Inc. (NYSE:RYAN) offers specialized products and services to insurance brokers, agents, and carriers. The company operates as both a wholesale broker and a managing underwriter with delegated authority, delivering solutions that include distribution, underwriting, product development, administration, and risk management. While we acknowledge the potential of RYAN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.

Ryan Specialty Holdings (NYSE:RYAN) Amends Certificate Of Incorporation After Stockholder Vote
Ryan Specialty Holdings (NYSE:RYAN) Amends Certificate Of Incorporation After Stockholder Vote

Yahoo

time05-06-2025

  • Business
  • Yahoo

Ryan Specialty Holdings (NYSE:RYAN) Amends Certificate Of Incorporation After Stockholder Vote

Ryan Specialty Holdings recently approved amendments to its bylaws at the 2025 annual stockholders meeting. During the past month, the company's share price experienced an increase of 3.6%. This movement aligns with a broader market uptick, where the Dow Jones, S&P 500, and Nasdaq indices also reported gains amid positive trade discussions between the U.S. and China. The amendments in the company's corporate structure might have added some weight to its share price progress, though its movement mainly mirrored the general market trend of rising investor confidence during this period. You should learn about the 4 risks we've spotted with Ryan Specialty Holdings (including 1 which is concerning). Find companies with promising cash flow potential yet trading below their fair value. Ryan Specialty Holdings' recent bylaw amendments could influence its revenue and earnings predictions by bolstering investor confidence, potentially supporting positive market sentiment and share price momentum. Over the past three years, Ryan Specialty achieved a total return of 88.26%, indicating significant long-term value growth for shareholders. This is particularly notable, as the company outperformed the US Insurance industry and broader market over the past year, surpassing their respective returns of 19.6% and 12.6%. The amendments may impact analysts' revenue and earnings projections, which already anticipate Ryan Specialty's revenue to grow by 18.3% annually over the next three years. This growth is expected alongside a substantial increase in profit margins from 2% to 27.1%. However, factors such as reliance on acquisitions and economic uncertainties remain key considerations. The company's current share price of US$69.23 remains 8.8% below the analyst consensus price target of US$75.9, suggesting analysts see further room for potential growth. As always, it's crucial for investors to evaluate these factors against their own assumptions. Examine Ryan Specialty Holdings' earnings growth report to understand how analysts expect it to perform. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:RYAN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store